Get the Weekly Intelligence Brief — top committee picks every Sunday.

GMED vs SRRK

Globus Medical vs Scholar Rock Holding Corporation — AI-powered side-by-side comparison
GMED
Globus Medical
71
Buy
VS
SRRK
Scholar Rock Holding Corporation
57
Watch
MetricGMEDSRRK
AI Score 71 57
Price $85.12 $52.11
P/E Ratio 21.45× -15.73×
ROE 11.8% -154.0%
Revenue Growth YoY
Gross Margin 68.5% 0.0%
Debt / Equity 0.02× 0.80×
Dividend Yield 0.0% 0.0%
RSI (14) 75.9 60.3
Beta 0.954 0.666
Expected Upside +0.1%

AI Committee View

Current Innellis committee reasoning for GMED versus SRRK.
GMED leads by 14 points.

GMED scores 71/100 (Buy) versus SRRK at 57/100 (Watch).

GMED Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
SRRK Committee View
60% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 18.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Price-to-book of 18.3x prices in significant intangible value — Value
  • ROE of only -159.1% -- cheap may mean cheap for a reason — Value
  • Bollinger bandwidth of 18.2% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GMED Full Analysis SRRK Full Analysis